Progress in clinic diagnosis of sera aquaporin-4 antibody negative neuromyelitis optica / 天津医药
Tianjin Medical Journal
;
(12): 548-552, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-608196
ABSTRACT
According to the sera aquaporin-4 antibody (AQP4), neuromyelitis optica (NMO) can be classified into two types as AQP4 antibody positive (AQP4+) and negative (AQP4-). However, the NMO patients with AQP4- are prone to delayed treatment, and may have a different pathogenesis compared to that in patients with AQP4+. Scientific researches and the clinical trials on NMO with AQP4- will deepen the understanding of NMO pathogenesis and help to make an early accurate diagnosis and rational therapy for NMO with AQP4-. This review aims to summarize the progress in clinic diagnosis for NMO patients with AQP4-.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
Chinese
Journal:
Tianjin Medical Journal
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS